Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Unleashing the Power of Flexible Isolators: Insights from Onfab’s Director Mike Brown

Flexible isolators are a crucial component in pharmaceutical processing, and Onfab’s Director and Containment Specialist, Mike Brown, offers invaluable insights into their applications. Boasting an impressive repertoire of over 6,500 designs, Onfab caters to diverse processing parameters and GMP classifications, providing comprehensive solutions to meet various requirements. The retrofit isolators offered by Onfab elevate a…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from Benchmark Products on MarketScale.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

Flexible isolators are a crucial component in pharmaceutical processing, and Onfab’s Director and Containment Specialist, Mike Brown, offers invaluable insights into their applications. Boasting an impressive repertoire of over 6,500 designs, Onfab caters to diverse processing parameters and GMP classifications, providing comprehensive solutions to meet various requirements.

The retrofit isolators offered by Onfab elevate a process equipment capabilities, enabling the safe handling of high-potent compounds and expanding product catalogs. Additionally, standalone systems offer enhanced protection for operators dealing with hazardous active pharmaceutical ingredients. Onfab’s meticulous focus on materials like polyurethane, polyethylene, and PVC ensures optimal solvent compatibility and containment efficacy. Prioritizing ergonomics and operator comfort, Onfab’s flexible isolators mitigate fatigue and minimize the risk of injuries during operations.

Strengthening the safety of flexible containment systems, high-containment zippers, and gloves play a pivotal role. Onfab’s isolators undergo stringent qualification processes, including performance testing down to nanogram levels, ensuring their effectiveness. Partnering with Benchmark Products, Onfab facilitates expedited delivery and storage of isolator kits, enabling agile responses to evolve processes and plans. Let’s dive deeper into the realm of flexible containment and worker safety in pharmaceutical processing with Mike Brown in this episode.

Video TranscriptExpand ↓

So on fab offer a range of flexible isolators and they cover all aspects of processing from oral solid dose through tapeICin assist even down into sort of antibody drug conjugation. Those isolators cover all the types of processing within those parameters. So we have million isolators, we have isolators for dispensing, for tablet presses. You you name it. We've pretty much covered all those aspects. We have around six and a half thousand designs for isolators. So you can imagine within that range, we have covered all aspects including all GMP classifications as well. So if they're an isolator needs to have a nitrogen inertia internally or if there is any particular temperature control, then onfap has the ability to apply that via, basically, technology. So with the the the two different types we've broken our isolators into is a retrofit and then our stand alone isolator range. So a retrofit ice is an isolator that we apply to your process equipment and that then therefore upgrades the capabilities of that process equipment. To allow it to handle more high potent compounds. Therefore, open up such a broader catalog of of products that you can sort of manufacture with those pieces of equipment. And and as I said within those six and a half thousand designs, we've covered all processing parameters. Then our second look line is the standalone systems. So a standalone system is an isolator that provides you with a a space in which you can place a process internally. Began giving you the increased level of protection when you're handling these hypovern active pharmaceutical ingredients. And it really helps support that processing parameters and the protection of those operators when they're handling these poking compounds. So Onfab has a range of films that we utilize for our flexible containment isolators. And they are polyurethane, which is our standard film, obviously comes with anti static and various different FDA approvals and food safe approvals as well for our European clients. Then from that, we have polyethylene, which we make a small amount of isolators from more transfer technology than an actual physical isolators. And we also utilize PVC. Now, the the classification and why we choose those films is based around solvent compatibility we need with the isolators. So obviously polyurethane will have a different solvent compatibility to polyethylene and then to PVC. And we pick them and select them which is most appropriate for the technology that we're trying to contain. Moving on from that, we spent a lot of time looking at ergonomics and and the standard person. I'd do that because everybody I don't know what a standard person looks like. But yeah, we talk about the standard person and to the measures the elbow and to where their shoulders lie. Because what we don't want is people working like this. We want them to be in a natural position when they are operating our eyesight. Therefore, you are limiting their fatigue and also not causing any additional levels of injury to our our operators whilst they're utilizing the isolator technology. And then there's other things on the isolators which are really important to help increase that potential operate to protection. So we have our h fourteen separated cam fill filters. So we're like ninety five percent of an on for isolator would run under a negative pressure. And that then is driven by our our automated fan system, put plus our h fourteen separated filters. Those h four those h fourteen separated filters maintain the pressure inside the isolator with the fan unit and then keep a constant change of air internally. So you not only are you getting operator protection but you're getting an increase in GMP in in inside the isolator as well. And we utilize a range of zippers on our isolators and and they are all high containment zippers. And the reason for that is is that it's possibly as one of the weak points of a flexible system is on the transfer where you're bringing things in and out. So you want that to be strong as possible when you're operating the isolator. So we apply our what we call our black zipper, but it's our strong high high containment zipper on our isolator them. And we have a range of gloves. So again like the films, gloves have compatibility. So depending upon what the operator is handling inside isolator, whether it is small, dextrous operations or whether it's full transfer, then we have a range of gloves for it to handle those applications as well. So supporting again that operates in an ergonomical sense. So on path isolators are subjected to the same level of qualification, there's a rigid isolator would do. So along traditionally, it is installation qualification, operational qualification and performance qualification. When we're referring to the containment performance target that the isolated needs to achieve to deliver the amount protection needed for the products that you're about to process, then we're talking about performance qualification. And that is done via a CPT which containment performance testing. It's driven by the ISP. There's guidance from the ISP as to how that is taken how that takes place. However, traditionally, it is a air monitoring. So you check the concentrations within the air of outside of the isolator, and that will determine that that there is no product lead from the isolator itself. It's normally done in micrograms per meter cubed, but now we are being trialed even down to the low nanogram levels of containment performance. And they are subjected by taking a slight, a small pump. The pump simulates the breathing of a of a personnel, and you have a small little sampler on your lapel normally and that that will then check how much of the particular surrogate that you're using in the CPT is is on that filter face and then they test that and it becomes a it gives you a level of of containment performance for the isolators. Now with the installation qualification and operational quality application. If you have the three stages including the performance qualification, then you get a full range of validation for that isolator. Of the installation qualification will ensure that the isolator is is as designed. The operational qualification will also support the IQ that will support on the basis that the operators can actually physically do what's needed to be done inside the isolator. The partnership of On fab and Benchmark opens up the US market to something that quite new. So on fab's expertise in flexible containment systems has been benefited all over Europe for many years. And and with our partnership with Benchmark, it's allowing us to enter into the US marketplace. Now the main one of the main benefits of of having bench Markwork alongside on purpose is the fact that they have a fantastic facility based in Chicago. So they will be able to stock your replenishment isolators in the form of kits. Those kits then can be stored at benchmark for very very quick delivery. Approximately five days as one of the maximum deliveries. So instead of waiting long periods for the isolators to be shipped from from the UK, you can have them stored as an open order with with benchmark products and and be delivered within those five day periods. So it helps you not having to be able to store those systems in your own warehouse or freeing up space in your warehouse. But also the the main thing is is that as we know, processes and and sort of plans change. So that being able to react very quickly with having those isolated stored with Benchmark in Chicago. Means that you you have that sort of safety net of of additional isolators ready for use.

Benchmark Products

Part of this channel

Benchmark Products

ISO-certified cleanroom supplies for life science manufacturers.

Visit the channel

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Dental practice exits are turning into multi-year projects, not last-year decisions

Dental practice exits are turning into multi-year projects, not last-year decisions

Dental practice exits now take 3–5+ years of prep. Dental Economics says associate-to-buyout timelines often run three to five-plus years. That pushes revenue-cycle controls, buy-sell terms, and tax structure earlier, before a buyer appears.

  • 01A practical benchmark is emerging for succession: bringing in an associate with intent to buy can take a minimum of three years and often more than five, according to Dental Economics.
  • 02If accounts receivable looks “high,” it may be a bookkeeping and posting problem before it is a payer problem, a revenue-cycle diagnostic Group Dentistry Now says shows up frequently at scale.
  • 03Exit planning is now an operating system project: valuation, tax positioning, and transition support belong in the same workstream, because deal structure can lock in or foreclose tax options, per Dental Economics.

Sep 4, 2026

Scan.com’s $220M round makes imaging an API contract for plans and employers

Scan.com’s $220M round makes imaging an API contract for plans and employers

Scan.com closed $220 million in equity and debt. It’s expanding its U.S. imaging network plus API-based scheduling and results delivery. For health plans and employers, imaging is starting to look like a platform procurement and integration decision, not a directory problem.

  • 01If imaging access is bought via an API, the real spec becomes integration depth: two-way scheduling plus results routing into the EMR, according to Business Wire.
  • 02Scan.com’s mix of $90M equity and $130M debt earmarked for M&A and working capital points to a fast-changing imaging provider network, which can help access but demands discipline in contracting and integration testing.
  • 03The same week’s funding news for Elucid ($55M) suggests AI imaging vendors will keep pushing toward FDA-cleared workflow insertions, a different buying path than network-layer platforms.

Sep 4, 2026

MD&M West 2026 exhibitors pitch audit-ready, AI-ready device platforms

MD&M West 2026 exhibitors pitch audit-ready, AI-ready device platforms

MD&M West 2026 exhibitor messaging suggests compliance testing and AI-ready compute are becoming early decisions, not afterthoughts. Medical Economics described 2026 as a period shaped by rapid technological change, regulatory scrutiny and ongoing economic uncertainty. Medical Design & Outsourcing’s MD&M West 2026 preview points to exhibitors highlighting test equipment, contract manufacturing and other launch support services.

  • 01If a device roadmap includes AI features, the critical path shifts toward data and software evidence that regulators can audit, which means earlier lock-in of compute platforms and test plans, pulling verification and validation into supplier selection.
  • 02MD&M West exhibitor messaging suggests verification and validation capacity is becoming a procurement problem, with rentals and lab-ready gear positioned as a way to avoid booking delays and re-tests, according to Medical Design & Outsourcing.
  • 03With imaging and other new procedural and device concepts moving fast, manufacturing leaders should expect more frequent line-change decisions and component qualification work, as GE HealthCare's photon-counting CT CE mark reported by MedTech Dive and MDDI's New Technologies coverage illustrate.

Sep 3, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512